Skip to main content
OpenTrials
Completed

NCT Number: NCT01587183

Running Against Prehypertension Trial (RAPT): A Pilot Trial

This study will test strategies to help people with prehypertension adopt a running program to reduce their blood pressure in the long term. This study will be a 12 week intervention of about 40 participants randomized to running educational material, group based running instruction, or group based running instruction focused on form and all given the option to use the supplemental mHealth intervention. The purpose of this study is to collect feasibility, acceptability and preliminary efficacy data in preparation for a larger planned NIH-R01 study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Osher Center for Integrative Medicine

San Francisco, California, 94115, United States

About this study

The UCSF Osher Center for Integrative Medicine has increasingly been investigating lifestyle interventions and their upstream approach to improving health and well-being. Many such lifestyle interventions address health risk nonpharmacologically and present participants with the opportunity to change their overall trajectory of health. Exercise interventions are of particular interest based on evidence of numerous physical and mental health benefits. Our target population in the Running Against Prehypertension Trial (RAPT) was people with upper range prehypertension. By adopting and maintaining a running program, these individuals who are at a high risk of hypertension can avoid a lifetime of medication and chronic disease. The objective of RAPT was to collect feasibility, acceptability and preliminary efficacy data over a 12 week period on a running program aimed at teaching a natural running form called ChiRunning that used the mindful movement principles of Tai Chi. By using this natural running form, participants may increase satisfaction and decrease rates of injury towards greater adherence to the program. Participants were randomized to one of three study arms: 1) intervention, 8 weeks of group training in form focused ChiRunning; 2) active control, 8 weeks of group training focused on conventional running excluding form; or 3) usual care, a self-directed training with educational materials.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The target population for our proposed study is adults with upper range prehypertension defined by systolic blood pressure in the range of 130-144mmHg or diastolic blood pressure range in the range of 85-94mmHg.
  • Potential participants will have two to three blood pressure screening measurements at least one day apart taken to screen for eligibility.
  • Participants also must not be currently taking antihypertensive medications and must live in the San Francisco Bay Area.

Exclusion criteria

  • Inability to provide informed consent
  • Age < 18 years
  • Inability to run continuously for 5 minutes (required for the gait analysis)
  • A substance or alcohol abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential subject to participate in the group intervention
  • A history of cardiovascular disease or coronary artery disease including acute coronary syndrome, heart failure, severe aortic stenosis, acute infection or fever, or resting tachycardia (> 100 bpm)
  • A history of cardiac procedures including coronary artery bypass graft, angioplasty or stent placement.
  • Typical or atypical angina
  • Arrhythmia, alcoholism or other condition that makes accurate BP measurement difficult
  • A diagnosis of diabetes, chronic kidney disease or other condition indicating medication for SBP < 140mmHg
  • Non-English speaking (group training will be given in English)
  • Pregnant or planning to get pregnant during the study period
  • Unwillingness or inability to commit to run/walking up to 30 minutes three times per week
  • Plans to move from the San Francisco Bay area during the study time period
  • Currently exercising at vigorous intensity for greater than 90 minutes per week. Vigorous intensity exercise may include race walking, jogging, running, hiking, swimming laps, or bicycling ≥ 10 miles per hour.
  • BMI > 30

Treatment and study plan

Educational material control

Behavioral

Participants will be given educational materials on starting a running program using a run/walk approach.

Group running style B

Behavioral

Participants will attend a 4 hour group based training and 3, 2 hour follow up trainings.

Group running style A

Behavioral

Participants will attend a 4 hour group based training and 3, 2 hour follow up trainings.

Primary outcomes

  1. Feasibility of recruitment and retention

    Time frame: At the end of the 8 week recruitment period

    We will determine feasibility associated with recruitment n by recruiting and retaining at least 75% of our intended sample.

  2. Feasibility and acceptability of study protocol and materials

    Time frame: At the end of the 12 week study

    We will conduct both qualitative and quantitative analysis of the evaluations provided by participants to improve study protocol and materials and to indicate feasibility and acceptability of the study content. We will consider at least 75% of participants being "satisfied" or higher in the overall study evaluation to indicate acceptability of the study materials. We will consider completing at least 75% of the intended gait analyses and feedback from the lab specialists to indicate feasibility and a "satisfied" or higher score by at least 75% of participants as being acceptable.

  3. Preliminary efficacy data on changes in blood pressure

    Time frame: Change in systolic and diastolic blood pressure from baseline at the end of the 12 week study

    For the preliminary efficacy data we will compare systolic and diastolic blood pressure changes between baseline and post intervention to determine effect size to make sample size calculations for a larger planned trial.

Secondary outcomes

  1. Preliminary efficacy data on injury incidence

    Time frame: At the end of the 12 week study

    For the preliminary efficacy data on injury incidence across the three study groups. Data on injury incidence will be collected using the training diary questions about whether a run was missed due to injury.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Registry information

Official study title

Running Against Prehypertension Trial (RAPT): A Pilot Randomized Controlled Trial

Acronym: RAPT

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Apr 30, 2012
Registry last updated
Aug 21, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.